More sensitive cell therapy may be a HIT against solid cancers
Peer-Reviewed Publication
Updates every hour. Last Updated: 24-Jun-2026 20:17 ET (25-Jun-2026 00:17 GMT/UTC)
HIT cells—a close cousin to CAR T cells—eradicate kidney, pancreatic, and ovarian cancers in mice and could remove a major impediment to cell therapy against many solid tumors.
Unlike some other forms of lymphoma, advanced stage follicular lymphoma has been considered incurable. But a new analysis of long-term data on patients treated for the disease years ago with standard regimens of immunotherapy and a chemotherapy combination known as CHOP suggests that many of those patients can now be considered cured, findings that could have major implications for care planning and research directions. The analysis is just published in the journal JAMA Oncology.
Humans differ from other primates due to their relatively large, permanent breasts, and their development has so far not been conclusively explained. According to a study conducted at the University of Oulu, Finland, the surface temperature of the breasts combined with their size and shape may help a newborn maintain body temperature.
Serial liquid biopsies showed that emerging AR alterations are linked to poorer outcomes in metastatic prostate cancer. Study suggests that a single genomic test at dx is no longer sufficient for managing advanced prostate cancer; supports real-time molecular testing to guide more personalized care.
Cancer treatment can take a profound financial toll, and new research shows the damage does not stop at the bank account. Nearly half of patients experience significant “financial toxicity,” and that strain quietly chips away at hope and social support, two pillars that sustain people through illness. As those erode, overall satisfaction with life declines. The findings suggest that addressing the cost of care is not only a financial issue but a psychological one, and that protecting patients’ hope and sense of connection may be just as critical as covering their bills.